Silence Therapeutics Plc American Depository Share (SLN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Silence Therapeutics Plc American Depository Share (SLN) is Neutral.

The composite score behind that read is -0.01, weighing +0.54 of bullish evidence against -0.27 bearish.

Silence Therapeutics Plc American Depository Share last closed at $9.86, +3.57% on the session.

Against the IVW growth benchmark the position is +2.77% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

1 graded prediction for SLN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Silence Therapeutics Plc American Depository Share in the 10th percentile on return on equity, where 100 is best.

Silence Therapeutics Plc American Depository Share is classified under Health Care / Biotechnology, with a market capitalisation of $573.19M.

StockMap tracks Silence Therapeutics Plc American Depository Share as the 168th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Silence Therapeutics Plc American Depository Share ranks 119th of 381 in the group, against a group median of -0.08.